Background: Gestational hypertension is defined as hypertension arising after mid-pregnancy 
Introduction
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress, that becomes more pronounced in preeclampsia. Preeclampsia, more prevalent in first pregnancies is associated with the highest maternal and fetal morbidity and mortality of all the pregnancy complications [1, 2] .
Preeclampsia is a rise in blood presure with proteinuria and gestational hypertension is a rise in blood pressure without proteinuria during the second-half of pregnancy. The diagnosis of gestational hypertension covers women with the preeclampsia who have not yet manifested proteinuria as well as women who do not have the preeclampsia syndrome [3] . Approximately 50 % of women with gestational hypertension with onset at < 30 weeks develop preeclampsia [4] .
Preeclampsia is associated with lipid peroxidation and is a key contributing factor to the pathophysiologic condition of preeclampsia. High levels of serum hydroperoxides and increased susceptibility of lipid peroxidation indicates preeclampsia to be associated with high oxidative stress [5] . Oxidative stress is a disturbance in the prooxidant antioxidant balance leading to potential damage. The ischemia/reperfusion injury associated with preeclampsia promotes both placental damage and release of factors leading to maternal endothelial dysfunction, and it has been postulated that alteration in the antioxidant activity may enhance endothelial cell oxidative damage. [6, 2] Studies regarding the antioxidant status in gestational hypertension are varied [7, 8, 9] .
Whilst proteinuria (defined here as the urinary excretion of ≥ 0.3 g protein in a 24-hour specimen), is not essential for the diagnosis of preeclampsia, it is the common clinical and diagnostic feature of the disorder in women with hypertension [10] . Preeclampsia is considered to be associated with increased vascular permeability leading to albumin loss from the intravascular spaces. Although hypoalbuminemia is common in pregnant women with preeclampsia, the impact of hypoalbuminemia on maternal and fetal morbidity in preeclampsia is not as yet well known [11] .
Therefore the present study aimed at elucidating the effect of gestational hypertension on copper, ceruloplasmin, total proteins and albumin levels.
II. Methods
A cross-sectional study was undertaken in Dr Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Andhra Pradesh, India. This study was conducted over a period of 15 months February 2011 to April 2012. It included 150 women; comprising of three groups, 50 cases diagnosed with gestational hypertension, 50 cases of age matched normal pregnant women and 50 age matched non-pregnant women were included in our study. The patients were randomly selected from the Obstetrics and Gynecology Department of the Institute. The study was approved by Institutional ethical committee.
History was taken regarding age, parity, past history, family history and present history. General examination of all systems was done; blood pressure, pulse and respiratory rate were recorded. Blood pressure was recorded in the right arm in supine position and the fifth korotkoff sound was taken as the diastolic pressure.
Pregnant women who were primigravida with a sustained raise of blood pressure of ≥140/90mmHg (two measurements), with /without proteinuria were included in the study. Known cases of diabetes, hypertension or any systemic disorders were excluded from the study. Cases with haemoglobin levels < 11g/dl and having urinary tract infection were excluded from the study after screening.
Unhaemolyzed samples of 3ml venous blood was collected under aseptic conditions and were analyzed for copper, ceruloplasmin, total proteins, albumin, AST, ALT and creatinine levels. They were analyzed in the Randox-Daytona autoanalyzer. Estimation of ceruloplasmin was done by turbidometric method, copper by colorimetric method, total proteins by biuret method, albumin by bromocresol green method, liver enzymes AST and ALT, and serum creatinine by kinetic method. Urinary protein was estimated by dipstick method and 24 hr urinary protein estimation.
Statistical analysis was done using graph pad prism version 6. ANOVA analysis was done to compare the variables. P value < 0.05 was considered to be statistically significant.
III. Results
The mean age in years of the non-pregnant, normal pregnant and gestational hypertension cases were 22.7±1.66, 23.18±2.10, 25.58±2.40 respectively. The mean systolic and diastolic pressure in mm/Hg of the nonpregnant, normal pregnant and gestational hypertension cases were 120.68±11.14, 125.78±7.88, 149.7±6.17 and 76.96±6.6, 79.08±6.06, 99.52±5.49 respectively.
The mean gestational age in weeks of the normal pregnant women and women with gestational hypertension was 29.7±2.92 and 29.18 ±3.32 respectively Proteinuria of < 1+ ( traces) was detected in 6% of healthy pregnant women and in 23% of women with gestational hypertension by dipstick. 24 hrs urinary protein estimation for these cases showed a value of < 100mg/day for normal pregnant and < 120mg/day for women with gestational hypertension. No proteinuria was detected in non pregnant women.
Comparison of various parameters of non-pregnant women with normal pregnant women and women with gestational hypertension has shown statistically significant increase in copper and ceruloplasmin levels and a statistically significant decrease in total proteins and albumin levels, with p < 0.05 for all the variables. Although mild increase of liver enzymes was noted in normal pregnant women and women with gestational hypertension, no statistical difference was noted for the liver enzymes and serum creatinine between the three groups [ Table 1 ]. 
IV. Discussion
Preeclampsia occurs after the 20 th week of gestation. It is a placental dependent disorder with both local intrauterine and systemic signs and symptoms. It has been proposed that the pathophysiology of preeclampsia develops in two stages, with reduction in placental perfusion as stage 1 of preeclampsia and the maternal syndrome as stage 2. It has been suggested that oxidative stress is responsible for the transition from stage one to stage two [12] .
Recent evidence indicates an increased inflammatory response in normal pregnancy that is further augmented in preeclampsia [13] .There are suggestions that nutrients or micronutrients may modify the inflammatory response [14] . Copper is an essential cofactor for many enzymes including cytochromes, but it is toxic in its unbound form. Therefore it can act as a pro-oxidant as well as antioxidant. During pregnancy plasma copper concentration significantly increases, returning to normal non pregnant values after delivery. The increase in copper with the progression of pregnancy could be partly related to synthesis of ceruloplasmin, a major copper binding protein due to altered levels of oestrogen [15] .
Ceruloplasmin is an acute phase reactant and its expression has been shown to increase under hypoxic conditions [16] . Concentrations of the acute phase reactants are up regulated during infection, inflammation and tissue trauma, mediated by inflammatory cytokines. [17] Ceruloplasmin has ferroxidase activity and since long, has also been considered as a plasma antioxidant due to its ability to react with and scavenge toxic substances like superoxide and hydrogen peroxides [18] .
Studies have shown that placental factors are involved in the pathophysiology of preeclampsia. It has been postulated that in severe preeclampsia there is an increase in placental ceruloplasmin following hypoxia, indicating that placental ceruloplasmin, a protein with antioxidant properties expression is clearly upregulated in the preeclampsia groups [6] .
Our study showed statistical significant rise in the serum copper and ceruloplasmin levels in healthy pregnant women and in women with gestational hypertension, on comparison with non-pregnant women. These findings were in agreement with other studies [9, 19, 20] .
Studies have demonstrated proteinuria in normal pregnant women and women with gestational hypertension. In Preeclampsia there is marked hypofiltration due to reduction in renal plasma flow and GFR. There is a loss of glomerular barrier charge and size selectivity which normalizes postpartum [21] . Hypoalbuminemia is explained by an increase in plasma and interstitial volume and possibly by an increase in albumin metabolism. Increase in capillary permeability secondary to endothelial damage seems to be partly responsible for this finding [22] .
Adedeji AL et al [23] has observed that compared with non pregnant women, the concentration of total proteins, albumin, were not significantly decreased in normotensive pregnant women. Olooto WE et al [24] and Arinola G et al [25] , showed that total proteins and serum albumin levels were significantly decreased while urinary protein was significantly increased in pregnancy related hypertension and preeclampsia groups respectively as compared to normal pregnant women Our study showing a statistical significant decrease in total proteins and albumin levels in healthy pregnant women and in women with gestational hypertension compared to non pregnant women and is in accordance with the above studies.
Key points
 Gestational hypertension /preeclampsia is a multisystem disorder based on a cascade of immunopathological events originating from the placenta. No single candidate mechanism exists to explain the complex pathogenesis.  From present study it is concluded that the increase in ceruloplasmin levels appear to be secondary to oxidative stress and an increase in copper levels to the fact, that incorporation of copper is essential for ceruloplasmin activity. A decrease in glomerular filtrate rate and renal blood flow probably accounts for a decrease in the levels of total proteins and albumin.
